BL
Benjamin Lerman
Co-Founder & CEO at DINYA DNA
· San Francisco, California, United States
Check size
Undisclosed
Lead stage
Seed
Deals tracked
2
Sectors
Biotechnology, Healthcare
Biotechnology
Healthcare
DNA Technology
Seed
Series A
San Francisco
California
United States
About Benjamin
Benjamin Lerman is an Executive Officer and Director with experience in institutional investment and corporate governance. Limited public data is available to confirm specific firm affiliation, investment stage focus, or sector specialization
Investment thesis
Co-Founder & CEO building DNA-based solutions at DINYA DNA
As Co-Founder and CEO of DINYA DNA, Ben Lerman leads the development of innovative DNA-based technologies to address critical challenges in biotechnology and healthcare. His focus is on translating scientific breakthroughs into practical, scalable solutions that improve outcomes for patients and industries alike.
Recent activity
Live platform data · proprietary, citable layer
Notable portfolio
DINYA DNA founding and growth
Frequently asked
Does Benjamin Lerman invest at Seed stage?
Yes. They invest at Seed, Series A stage.
Their geographic focus includes San Francisco, California, United States.
What is their typical check size?
Check size is not publicly disclosed. They currently invest through DINYA DNA.
What sectors does Benjamin Lerman focus on?
Benjamin Lerman primarily invests in Biotechnology, Healthcare, DNA Technology.
Similar Biotechnology investors
FK
Frank Kung
Healthcare · Undisclosed
RW
Rob Wilder
Food & Agricultural Technology · Undisclosed
FT
Fernando Torres Navarrete
Biotechnology · Undisclosed
Samuel Alworth
Biotechnology · Undisclosed
Sign up for free to unlock similar investors
Are you a fit for Benjamin Lerman?
See your match score free · under a minute